Want to join the conversation?
$CAH said Medical segment revenue for 4Q16 grew more than 12% to $3.2Bil, primarily due to acquisitions and Cardinal Health Brand products. Segment profit in 4Q16 grew more than 19% to $122MM due to acquisitions and growth in Cardinal Health Brand products.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)